Dianlin Xie
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (Sweden)(SE)Bristol-Myers Squibb (Belgium)(BE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Protein Kinase Regulation and GTPase Signaling, Enzyme Structure and Function, Cytokine Signaling Pathways and Interactions, Melanoma and MAPK Pathways
Most-Cited Works
- → The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants(2006)678 cited
- → Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165(2019)356 cited
- → Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation(2008)127 cited
- → Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities(2008)122 cited
- → Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain(2015)115 cited
- → Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase(2014)99 cited